A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Additional file 1: of Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1
[stub]
2019
Figshare
Preserved Fulltext
Table S1. Adverse events causing study discontinuation. Table S2. Cardiac adverse events reported by at least 2 patients in the pooled adverse events analysis (0.5% or more of total trials population). Table S3. Serious cardiac events. (PDF 127 kb)
doi:10.6084/m9.figshare.8244914.v1
fatcat:s2jepd4hofc4tetia6hdp5b3gm